Corrigendum to “Novel diketopyrrolopyrrole NIR-II fluorophores and DDR inhibitors for in vivo Chemo-photodynamic therapy of Osteosarcoma” [Chem. Eng. J. 446 136929]
【作者单位】1Department of Spine Surgery & Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China;2These authors contributed equally to this work.;3College of Science, Research Center for Ecology, Laboratory of Extreme Environmental Biological Resources and Adaptive Evolution, Tibet University, Lhasa 850000, China;4Center for Experimental Basic Medical Education, Institute of Myocardial Injury and Repair, Department of Cardiology, Zhongnan Hosipital of Wuhan University, Wuhan 430071, China;5Jiangxi Key Laboratory of Organo-Pharmaceutical Chemistry, Chemistry and Chemical Engineering College, Gannan Normal University, Ganzhou 341000, China;6Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan 430071, China;7State Key Laboratory of Virology, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai 264005, China;8Shenzhen Institute of Wuhan University, Shenzhen 518057, China
